216 - Challenging Cases in Transplant ID

Saturday, October 14, 2023

10:30 AM – 11:45 AM US ET

Location: 210 ABC

All relevant financial disclosures have been mitigated.

Interactive Moderator(s)

Maricar Malinis, MD

Associate Professor of Medicine and Surgery (Transplant)
Section of Infectious Diseases
Yale University
New Haven, CT, United States

Slides
Jennifer Cuellar Rodriguez, MD, DTM&H, FIDSA (she/her/hers)

Chief, Transplant Infectious Diseases
National Institute of Allergy and Infectious Diseases
Bethesda, MD, United States
Murat Akova, Prof. (he/him/his)

Professor
Hacettepe University
Ankara, Ankara, Turkey

Panelist(s)

John Baddley, MD, MSPH, FIDSA, FAST (he/him/his)

Professor of Medicine
University of Maryland School of Medicine
Baltimore, MD, United States
Meenakshi Rana, MD (she/her/hers)

Associate Professor
Icahn School of Medicine at Mount Sinai
Scarsdale, NY, United States
EC

Eric Cober, MD

Staff
Cleveland Clinic Foundation
Cleveland, OH, United States
Monica Ardura, DO, MSCS (she/her/hers)

Professor of Pediatrics, Infectious Diseases
Pediatrics, Infectious Diseases
Nationwide Children's Hospital
Columbus, OH, United States

Disclosure(s):

Maricar F. Malinis, MD: Shire/Takeda: Advisor/Consultant (Terminated, March 4, 2023)

Jennifer Cuellar Rodriguez, MD, DTM&H: No financial relationships to disclose

Murat Akova, Prof.: No financial relationships to disclose

John W. Baddley, MD, MSPH, FIDSA, FAST: Horizobn: Advisor/Consultant (Ongoing); Lilly: Advisor/Consultant (Ongoing); Novo Nordisk: Advisor/Consultant (Ongoing)

Meenakshi M. Rana, MD: Eli Lilly & Co.: advisory board (Terminated, December 31, 2021)

Eric Cober, MD: No financial relationships to disclose

Monica I. Ardura, DO, MSCS: Karius Inc.: Advisor/Consultant (Ongoing); Merck & Co., Inc.: Grant/Research Support (Ongoing); Miravista: Grant/Research Support (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe diagnostic conundrums in immunocompromised hosts;
recognize challenging therapeutic management of infections in immunocompromised hosts